S. Karakaya

发表

The neutrophil-lymphocyte ratio and its relationship with insulin resistance in obesity

M. Altay, D. Taner Ertuğrul, O. Bulur, 2019, Turkish journal of medical sciences.

Renal function improves with the treatment of hypothyroidism

D. Ertuğrul, E. Beyan, N. Ata, 2017, Endocrine research.

The Relationship Between Systemic Immune Inflammation Index and Treatment Response in Renal Cell Carcinoma Patients Treated with Tyrosine Kinase Inhibitors: Results from The Turkish Oncology Group Kidney Cancer Consortium Database

B. Öksüzoğlu, N. Karadurmuş, S. Kılıçkap, 2021 .

The effect of glycemic control on CEA, CA 19-9, amylase and lipase levels

D. Ertuğrul, E. Beyan, A. Yeniova, 2014, Open medicine.

Can neutrophil to lymphocyte ratio or platelet to lymphocyte ratio predict chemotherapy response testicular cancer

S. Karakaya, 2021 .

The relationship between prognostic nutritional index and treatment response in patients with metastatic renal cell cancer

U. Demirci, I. Çiçin, N. Karadurmuş, 2019, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

The relationship between systemic immune inflammation index and survival in patients with metastatic renal cell carcinomatreated withtyrosine kinase inhibitors

B. Öksüzoğlu, N. Karadurmuş, S. Kılıçkap, 2022, Scientific Reports.

Clinical Outcomes and Prognostic Factors in HER-2 Positive Breast Cancer with Brain Metastasis: A Single-centre Experience.

U. Demirci, O. Ates, S. Karakaya, 2021, Journal of the College of Physicians and Surgeons--Pakistan : JCPSP.

Clinicopathological Factors in Relation to HER2 Status in Metastatic Gastric Cancer: A Retrospective Observational Study

B. Savaş, E. Akkuş, N. Karadurmuş, 2022, Journal of Oncological Sciences.

The relationship between pan-immune-inflammation value and survival outcomes in patients with metastatic renal cell carcinoma treated with nivolumab in the second line and beyond: a Turkish oncology group kidney cancer consortium (TKCC) study

B. Öksüzoğlu, N. Karadurmuş, S. Kılıçkap, 2022, Journal of Cancer Research and Clinical Oncology.

Sunitinib or Pazopanib: Is There Any Difference Between Tyrosine Kinase Inhibitors in the Pre-Nivolumab Setting in Metastatic Renal Cell Carcinoma?

M. Dogan, M. Yılmaz, O. Bal, 2020, Cureus.

Clinicopathological features of non-carcinoid malignant epithelial appendix tumors and risk factors for recurrence, single-center experience

B. Aksel, V. Sunar, O. Ates, 2022, Indian Journal of Cancer.

Can neutrophil/lymphocyte ratio be used as an indicator of inflammation in patients with hyperthyroidism?

D. Ertuğrul, M. Altay, D. Yapar, 2019, Journal of medical biochemistry.

Immunohistochemical Evaluation of M30 and M65 in Barrett’s Esophagus and Esophageal Cancer

E. Beyan, G. Şimşek, Metin Uzman, 2021, Acta Oncologica Turcica.

Non-Invasive Liver Fibrosis Scores can Predict Hepatic Metastasis in Colorectal Cancers

S. Karakaya, 2022, International Journal of Hematology and Oncology.

Crizotinib efficacy and safety in patients with advanced NSCLC harboring MET alterations: A real-life data of Turkish Oncology Group

A. Bilici, S. Paydaş, E. Akkuş, 2022, Medicine.

Nivolumab in metastatic renal cell carcinoma: results from the Turkish Oncology Group Kidney Cancer Consortium database.

U. Demirci, B. Öksüzoğlu, M. Özgüroğlu, 2021, Future Oncology.

External Validation of a Novel Risk Model in Patients With Favorable Risk Renal Cell Carcinoma Defined by International Metastatic Renal Cell Carcinoma Database Consortium (IMDC): Results From the Turkish Oncology Group Kidney Cancer Consortium (TKCC) Database.

U. Demirci, B. Öksüzoğlu, M. Özgüroğlu, 2022, Clinical genitourinary cancer.

Ideal Lymph Node Number for Ovarian Malignancies

S. Karakaya, I. Karadag, 2022, Cureus.

High Neutrophil-Lymphocyte Ratio, Platelet-Lymphocyte Ratio and Low Lymphocyte Levels Are Correlated With Worse Pathological Complete Response Rates

M. Yılmaz, S. Karakaya, I. Karadag, 2022, Cureus.

Trimester-specific reference intervals of thyroid function tests in Turkish pregnants

D. Ertuğrul, E. Beyan, K. Dal, 2020, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

The Potential Prognostic Marker TyG Index Predicts Time to Brain Metastasis at HER2 Positive Breast Cancer

M. Dogan, E. G. Alkurt, T. Akkan, 2023, Cancer management and research.

Association of serum proprotein convertase Subtilisin/Kexin Type 9 (PCSK9) level with thyroid function disorders.

D. Ertuğrul, E. Beyan, O. Doğan, 2021, European review for medical and pharmacological sciences.

Evaluation of factors predicting pathologic complete response in locally advanced HER2 positive breast cancer treated with neoadjuvant pertuzumab, trastuzumab and chemotherapy; Real life data.

B. Yalcin, S. Aksoy, D. Uncu, 2021, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

Clinical Features and Prognostic Factors of Metastatic Non-Clear Cell Renal Cell Carcinoma: A Multicenter Study from the Turkish Oncology Group Kidney Cancer Consortium

B. Öksüzoğlu, M. Özgüroğlu, S. Kılıçkap, 2023, Urologia Internationalis.

Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy

Ö. Acar, A. Erdoğan, Kubilay Karaboyun, 2023, BMC Cancer.

The role of insulin - like growth factor - 1 on steatohepatitis.

D. Ertuğrul, E. Beyan, A. Yeniova, 2016, Acta gastro-enterologica Belgica.

Association of neutrophil-to-lymphocyte ratio and microalbuminuria in patients with normal eGFR

S. Karakaya, I. Karadag, Murat Eser, 2018, Romanian journal of internal medicine = Revue roumaine de medecine interne.

Neutrophil–lymphocyte ratio as a prognostic factor for survival in patients with advanced renal cell carcinoma (Turkish Oncology Group Study)

U. Demirci, B. Yalcin, I. Çiçin, 2020, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.